Document Type

Article

Publication Date

5-24-2014

Publication Title

BioMed Central Musculoskeletal Disorders

Abstract

As recommended in the current prescribing information, rituximab infusions in patients with rheumatoid arthritis (RA) take 4.25hours for the first infusion and 3.25hours for subsequent infusions, which is a burden on patients and the health care system. We therefore evaluated the safety of infusing rituximab at a faster rate for an infusion period of 2hours in patients with RA.

DOI

10.1186/1471-2474-15-177

Share

COinS